Details for New Drug Application (NDA): 062417
✉ Email this page to a colleague
NDA 062417 describes AZLIN, which is a drug marketed by Bayer Pharms and is included in three NDAs. Additional details are available on the AZLIN profile page.
The generic ingredient in AZLIN is azlocillin sodium. There is one drug master file entry for this compound. Additional details are available on the azlocillin sodium profile page.
The generic ingredient in AZLIN is azlocillin sodium. There is one drug master file entry for this compound. Additional details are available on the azlocillin sodium profile page.
Summary for 062417
| Tradename: | AZLIN |
| Applicant: | Bayer Pharms |
| Ingredient: | azlocillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062417
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Oct 12, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | Oct 12, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | Oct 12, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
